APA (7th ed.) Citation

Rengarajan, B., Hanvesakul, R., Stack, C., Wilson, F., Park, J., & Adeyemi, A. (2022). Indirect Treatment Comparison of Lurbinectedin vs. Other Second-Line Treatments for Small-Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics, 112(2), e18. https://doi.org/10.1016/j.ijrobp.2021.10.194

Chicago Style (17th ed.) Citation

Rengarajan, B., R. Hanvesakul, C. Stack, F. Wilson, J. Park, and A. Adeyemi. "Indirect Treatment Comparison of Lurbinectedin Vs. Other Second-Line Treatments for Small-Cell Lung Cancer." International Journal of Radiation Oncology, Biology, Physics 112, no. 2 (2022): e18. https://doi.org/10.1016/j.ijrobp.2021.10.194.

MLA (9th ed.) Citation

Rengarajan, B., et al. "Indirect Treatment Comparison of Lurbinectedin Vs. Other Second-Line Treatments for Small-Cell Lung Cancer." International Journal of Radiation Oncology, Biology, Physics, vol. 112, no. 2, 2022, p. e18, https://doi.org/10.1016/j.ijrobp.2021.10.194.